DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clorpres (Clonidine Hydrochloride / Chlorthalidone) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

CLORPRES SUMMARY

CLORPRES® is a combination of clonidine hydrochloride (a centrally acting antihypertensive agent) and chlorthalidone (a diuretic). CLORPRES® is available as tablets for oral administration in three dosage strengths: 0.1 mg/15 mg, 0.2 mg/15 mg and 0.3 mg/15 mg of clonidine hydrochloride/chlorthalidone, respectively.

CLORPRES® (clonidine hydrochloride USP/chlorthalidone USP) is indicated in the treatment of hypertension. This fixed combination drug is not indicated for initial therapy of hypertension. Hypertension requires therapy titrated to the individual patient. If the fixed combination represents the dosage so determined, its use may be more convenient in patient management. The treatment of hypertension is not static, but must be reevaluated as conditions in each patient warrant.


See all Clorpres indications & dosage >>

CLORPRES NEWS HIGHLIGHTS

Media Articles Related to Clorpres (Clonidine / Chlorthalidone)

Hypertension Develops Early, Silently, In African-American Men
Source: Hypertension News From Medical News Today [2008.11.18]

FREEDOM-C Trial Of Oral Treprostinil In Pulmonary Arterial Hypertension Fails To Meet Primary Endpoint
Source: Hypertension News From Medical News Today [2008.11.18]

Hypertension In Europe: A Worrying Scenario
Source: Hypertension News From Medical News Today [2008.11.12]

ASN: Rural Living Seen as Risk Factor for Pregnancy-Induced Hypertension and Preeclampsia
Source: MedPage Today Nephrology [2008.11.12]

Lipoprotein Levels May Predict Women's Hypertension Risk
Source: MedicineNet Cholesterol Specialty [2008.11.12]

more >>

Published Studies Related to Clorpres (Clonidine / Chlorthalidone)

The treatment of obese hypertensive black women: a comparative study of chlorthalidone versus clonidine. [1992.05]

Efficacy and safety of two-year therapy with transdermal clonidine for essential hypertension. [1988.05]

more >>

Page last updated: 2008-11-18

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008